Additionally, changes in gastrointestinal hormones, such as ghrelin, GLP-1, and PYY, have been observed in metabolic syndrome and obesity, with emerging evidence suggesting that ghrelin may be specifically associated with cancer proliferation and metastasis (11). Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.